Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Hayden

Showing results (51-60 of 391) with videos related to

Pageof 40
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 4, 2014
Editorial commentary: Host and viral factors in emergent influenza virus infectionsDavid S Hui, Frederick G Hayden
Infectious Disease Clinics of North America|June 1, 1987
Rimantadine hydrochloride and amantadine hydrochloride use in influenza A virus infectionsR L Tominack, F G Hayden
Cold Spring Harbor Perspectives in Medicine|February 12, 2020
Influenza Therapeutics in Clinical Practice-Challenges and Recent AdvancesJohn H Beigel, Frederick G Hayden
Antimicrobial Agents and Chemotherapy|April 1, 1988
Chemotherapy of rhinovirus coldsS J Sperber, F G Hayden
Journal of Clinical Microbiology|September 1, 1985
Comparative susceptibilities of strain MRC-5 human embryonic lung fibroblast cells and the Cooney strain of human fetal tonsil cells for isolation of rhinoviruses from clinical specimensF C Geist, F G Hayden
The Journal of Infectious Diseases|October 16, 2025
Introduction and Update: Advances in Influenza TherapeuticsFrederick G Hayden, Richard J Whitley
Annals of Internal Medicine|June 1, 1987
Antibiotics and chronic obstructive pulmonary diseaseS J Sperber, F G Hayden
Radiology|April 1, 1976
Palmar arteriography in acronecrosisC B Higgins, W G Hayden
Antimicrobial Agents and Chemotherapy|June 1, 1982
Prophylactic activity of intranasal enviroxime against experimentally induced rhinovirus type 39 infectionF G Hayden, J M Gwaltney
The Journal of Infectious Diseases|June 16, 2007
John F. Enders lecture 2006: antivirals for influenzaAdrian K Ong, Frederick G Hayden
Pageof 40

Showing results (51-60 of 391) with videos related to

Sort By:
Pageof 40
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 4, 2014
Editorial commentary: Host and viral factors in emergent influenza virus infectionsDavid S Hui, Frederick G Hayden
Infectious Disease Clinics of North America|June 1, 1987
Rimantadine hydrochloride and amantadine hydrochloride use in influenza A virus infectionsR L Tominack, F G Hayden
Cold Spring Harbor Perspectives in Medicine|February 12, 2020
Influenza Therapeutics in Clinical Practice-Challenges and Recent AdvancesJohn H Beigel, Frederick G Hayden
Antimicrobial Agents and Chemotherapy|April 1, 1988
Chemotherapy of rhinovirus coldsS J Sperber, F G Hayden
Journal of Clinical Microbiology|September 1, 1985
Comparative susceptibilities of strain MRC-5 human embryonic lung fibroblast cells and the Cooney strain of human fetal tonsil cells for isolation of rhinoviruses from clinical specimensF C Geist, F G Hayden
The Journal of Infectious Diseases|October 16, 2025
Introduction and Update: Advances in Influenza TherapeuticsFrederick G Hayden, Richard J Whitley
Annals of Internal Medicine|June 1, 1987
Antibiotics and chronic obstructive pulmonary diseaseS J Sperber, F G Hayden
Radiology|April 1, 1976
Palmar arteriography in acronecrosisC B Higgins, W G Hayden
Antimicrobial Agents and Chemotherapy|June 1, 1982
Prophylactic activity of intranasal enviroxime against experimentally induced rhinovirus type 39 infectionF G Hayden, J M Gwaltney
The Journal of Infectious Diseases|June 16, 2007
John F. Enders lecture 2006: antivirals for influenzaAdrian K Ong, Frederick G Hayden
Pageof 40